Filtered By:
Infectious Disease: Aspergillus
This page shows you your search results in order of date. This is page number 3.
Order by Relevance | Date
Total 481 results found since Jan 2013.
Introducing biomarkers for invasive fungal disease in haemato-oncology patients: a single-centre experience
Conclusions. Biomarkers can be used safely as part of a multidisciplinary approach to the diagnosis of IFD in neutropaenic haemato-oncology patients. Whilst they do not necessarily result in antifungal therapy being withheld, they can allow more confident diagnosis of IFD and more specific antifungal therapy in selected cases.PMID:35819894 | DOI:10.1099/jmm.0.001564
Source: Journal of Medical Microbiology - July 12, 2022 Category: Microbiology Authors: Anthony W Martinelli Callum B Wright Marta S Lopes Rosemary L Swayne Pramila Krishnamurthy Charles Crawley Ben Uttenthal George Follows Judith Babar Sani H Aliyu David A Enoch Clare R Sander Source Type: research
Severe asthma concomitant with allergic bronchopulmonary aspergillosis (ABPA) and non-steroid exacerbated respiratory disease (N-ERD) successfully treated with mepolizumab: A case report
Tuberk Toraks. 2022 Jun;70(2):215-219. doi: 10.5578/tt.20229815.ABSTRACTAllergic bronchopulmonary aspergillosis (ABPA) is a lung disease characterized by a hypersensitivity reaction to Aspergillus fumigatus. Allergic bronchopulmonary aspergillosis is characterized by increased serum IgE levels, peripheral blood eosinophilia and radiographic pulmonary infiltrates, central bronchiectasis, and mucus plugs. Mepolizumab, a monoclonal interleukin (IL)-5 antibody, reduces eosinophilic inflammation and improves symptom control in severe eosinophilic asthma. A 74-year-old male patient arrived at our allergy outpatient clinic compla...
Source: Tuberkuloz ve Toraks - July 5, 2022 Category: Respiratory Medicine Authors: Mehmet Erdem Çakmak Source Type: research
